Monopteros Therapeutics
Latest round
- Series A
Last raised
- Apr 2021
Total raised
- $20M
Investors
- 1
About Monopteros Therapeutics
Based in Massachusetts, US, and founded in 2019, Monopteros Therapeutics Inc. operates as a pharmaceutical research company that reprograms regulatory T cells (“Tregs”) for cancer immunotherapy resistance., and Ulrich von Andrian, MD.'s research team develops MPT-0118 that undergo a dose escalation and cohort expansion clinical trial. The MPT-0118 is provided as a tablet formulation for oral dosing in its Phase 1/1b clinical trial.
Who invested in Monopteros Therapeutics
1 investor across 1 round
See all investors in Monopteros Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 22, 2021
Amount
$20M
Investors
Questions about Monopteros Therapeutics
Who invested in Monopteros Therapeutics?
Monopteros Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Monopteros Therapeutics raised?
Monopteros Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Monopteros Therapeutics last raise money?
Monopteros Therapeutics's most recent round on record is a Series A, in Apr 2021.
What does Monopteros Therapeutics do?
Based in Massachusetts, US, and founded in 2019, Monopteros Therapeutics Inc.
Where is Monopteros Therapeutics headquartered?
Monopteros Therapeutics is headquartered in US.
Which VCs invest in companies like Monopteros Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Monopteros Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Monopteros Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.